Business
Novartis strikes deal with UK biotech for up to US$1.7 billion
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Novartis will pay UK biotech…
Tag
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Novartis will pay UK biotech…
Third-quarter operating income, adjusted for special items, rose to US$5.46 billion Swiss drugmaker Novartis, on a deal-making spree this…
Novartis agreed to buy Tourmaline Bio in a deal valued at about US$1.4 billion as the Swiss drugmaker continues to pursue bolt-on deals to…
Trump has repeatedly said he intends to impose tariffs on pharmaceuticals, citing the industry’s reliance on manufacturing sites around…